Bio-Techne Corp

Healthcare · Biotechnology

72.40$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 321 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TECH
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	277	273	303	306	289	297	316	317	287	296	311	321	1,215
Cost of Revenue	92	96	99	103	106	103	102	118	98	105	103	110	416
Gross Profit	185	177	205	203	183	194	215	199	188	191	208	211	799
Research & Development	24	23	26	24	24	25	25	26	24	23	23	24	95
Selling, General & Administrative	105	116	112	64	119	121	151	23	116	114	109	113	452
Total Operating Expenses	129	139	138	158	143	146	176	223	140	137	133	137	547
Operating Income	56	38	67	46	40	47	39	-24	48	54	75	74	252
Interest Expense	4.9	4.3	4.0	2.5	2.2	2.1	2.0	2.2	2.9	2.2	3.2	2.9	11
Pre-Tax Income	50	33	61	42	40	43	38	-23	48	51	71	71	241
Income Tax Expense	-1.4	5.9	12	1.1	6.6	8.0	16	-5.2	9.8	13	20	16	59
Net Income	51	27	49	41	34	35	23	-18	38	38	51	55	182
EBITDA	83	66	92	72	70	72	68	6.4	75	78	99	92	343

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings